News

MHRP investigators are participating in a new study that will help the military better understand how the infection affects members of the Army, Navy, Air Force and Marine Corps.

In his commentary for the Global HIV Vaccine Enterprise, COL Kim reflects on the RV144 trial.

Sixty-five MHRP staff now occupy a new LEED (Leadership in Energy and Environmental Design)-rated building at 6720A Rockledge Drive in Bethesda, MD.

RV144 and subsequent follow-on studies generated buzz at the 2011 AIDS Vaccine conference. Here we provide a roundup of some of the media highlights.

The world's only conference dedicated to HIV vaccine research wrapped up last week in Bangkok.

In this follow-up study, called RV152, researchers followed volunteers who became HIV infected during the RV144 trial to examine clinical outcomes over time.